Tirzepatide, still not approved in the EU for specific use in patients with obesity, is a dual agonist of the GLP-1 receptors and another incretin, gastric inhibitor polypeptide (GIP)
Safety Considerations for Post-Surgical Patients Bariatric patients have undergone significant anatomical changes, making careful medication selection essential
Buse informed Newsweek that UNC School of Medicine has received funding to provide consultation services to Novo Nordisk, among other pharmaceutical companies
The testing was performed in an open field chamber that measured 50 50 cm
Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib
Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics, and function through the PPAR-/PGC-1 signaling pathway